[Certain problems of pharmacodynamics, pharmacokinetics and the use of cardiac glycosides].
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002301:Cardiac Glycosides / Q000494:pharmacology*; D003327:Coronary Disease / Q000188:drug therapy*; D004074:Digitoxin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004077:Digoxin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004285:Dogs; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013328:Strophanthins / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use
D002301:Cardiac Glycosides; D013328:Strophanthins; D004077:Digoxin; D012964:Sodium; D004074:Digitoxin; D000251:Adenosine Triphosphatases; D011188:Potassium; D002118:Calcium
Nekotorye voprosy farmakodinamiki, farmakokinetiki i primeneniia serdechnykh glikozidov.